South Central Transit Authority

South Central Transit Authority, a U.S. local government transit authority based in Lancaster, Pennsylvania, is a federal grant recipient funding public transportation capital and operational improvements across two urbanized areas in Pennsylvania (Lancaster and Reading/Berks) as a prime recipient under the Federal Transit Administration (CFDA 20.507 and CFDA 20.526 programs).

South Central Transit Authority operates as a prime grant recipient on 37 of 43 recent federal awards, with the remaining 6 awards as a sub-recipient to the Pennsylvania Department of Human Services. The authority holds no federal contracts and does not compete on procurement vehicles; all federal activity flows through formula grants and project grants from the Federal Transit Administration. The organization receives supplemental sub-grant funding for Medical Assistance Transportation Program administration in Lancaster and Berks counties from the Pennsylvania Department of Human Services under Centers for Medicare and Medicaid Services pass-through funding.

The Federal Transit Administration accounts for 37 of 40 prime and sub awards (93% of the portfolio), with two distinct customer agencies across the recent footprint. Combined obligated dollars total $224.5 million across 43 awards spanning from 1999 through September 2026. Activity accelerated in 2026, with seven awards in the past year compared to single-digit annual counts in 2023–2025.

Representative recent prime grant work includes a $10.345 million Federal Transit Formula Grant (CFDA 20.507) awarded May 6, 2026, for replacement of 35-foot hybrid electric fixed-route buses, paratransit vehicles, roof and HVAC replacement, ADA paratransit service, and preventive maintenance in the Lancaster-Manheim urbanized area (ultimate completion December 1, 2028); a $7.5 million Federal Transit Formula Grant awarded August 13, 2026, for purchase of seven replacement 35-foot hybrid electric fixed-route buses for the Lancaster-Manheim area (completion June 23, 2028); and a $700,403 Buses and Bus Facilities grant (CFDA 20.526) awarded August 26, 2026, for hybrid electric bus purchases, facility and equipment renovation, ADA paratransit service, and finance software implementation (completion December 31, 2028). The authority also receives operational funding through American Rescue Plan Section 5307 grants, including a $7.39 million project grant to SCTA-Lancaster (March 2022) and a $9.509 million project grant to SCTA-Reading (March 2022) for COVID-19-related operating expenses.

In its sub-recipient role, South Central Transit Authority administers Medical Assistance Transportation Program services under a January 8, 2026, sub-grant from the Pennsylvania Department of Human Services, providing the least-costly and most appropriate transportation modes (taxicabs, vans, mini-buses, mass transit, paratransit, shared ride, and mileage reimbursement) for consumers in Lancaster and Berks counties traveling to medical facilities, physician offices, dentists, hospitals, clinics, pharmacies, and medical equipment suppliers. Three awards reach ultimate completion within the next twenty-four months, exposing minimal recompete near-term exposure relative to the organization's multi-year grant pipeline.